FTX and colorectal cancer: The FTX oncogenic activity in colorectal cancer progression is also mediated by ceRNA activity: FTX binds to miR-215, thus preventing the inhibition of the miRNA targets ZEB2, HOXB9, NOB1 and YY1 related to cell proliferation, migration and invasion; consistently, FTX knock-down suppresses cell proliferation, migration and invasion, and inhibits growth and metastasis in vivo [176].